Yahoo Finance Celgene Earnings, Revenue Beat in Q2
Investing.com - Celgene (NASDAQ:CELG) reported second quarter earnings that beat analysts' expectations on Tuesday and revenue that topped forecasts.
The firm reported earnings per share of $2.86 on revenue of $4.40B. Analysts polled by Investing.com forecast EPS of $2.63 on revenue of $4.24B. That compared to EPS of $2.16 on revenue of $3.81B in the same period a year earlier. The company had reported EPS of $2.55 on revenue of $4.03B in the previous quarter.
Celgene shares gained 1.03% to trade at $93.95 in pre-market trade following the report.
Celgene follows other major Healthcare sector earnings this month
On July 16, J&J reported second quarter EPS of $2.58 on revenue of $20.56B, compared to forecasts of EPS of $2.46 on revenue of $20.29B.
Pfizer earnings beat analysts' expectations on Monday, with second quarter EPS of $0.8 on revenue of $13.26B. Investing.com analysts expected EPS of $0.75 on revenue of $13.41B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar
Related Articles
Futures drop as eyes shift to Fed meeting, Apple earnings
Swiss help Japan's investigation into ex-Renault-Nissan boss Ghosn
Higher consumer spending helps Mastercard beat quarterly profit estimates
